Wang M H, Stec D E, Balazy M, Mastyugin V, Yang C S, Roman R J, Schwartzman M L
Department of Pharmacology, New York Medical College, Valhalla, New York, 10595, USA.
Arch Biochem Biophys. 1996 Dec 15;336(2):240-50. doi: 10.1006/abbi.1996.0554.
20-Hydroxy-5,8,11,14-eicosatetraenoic acid (20-HETE), the omega-hydroxylation product of arachidonic acid, is the major metabolite produced in the kidney. It has potent biological effects on renal tubular and vascular functions and on the long-term control of arterial pressure. The synthesis of 20-HETE is catalyzed by enzymes of the CYP4A family, among which CYP4A2 is the most abundant isozyme expressed in the kidneys of rats. We have cloned and sequenced the CYP4A2 cDNA from the kidney of Lewis-Wistar rats and directed its expression using baculovirus and Sf9 insect cells. A high level of expression of CYP4A2 was evident by Northern, Western, and spectral analyses revealing a P450 content of 0.3 nmol/mg microsomal protein. To study CYP4A2-catalyzed arachidonic acid omega-hydroxylation, Sf9 cells were coinfected with CYP4A2 and NADPH cytochrome P450 oxidoreductase (OR) recombinant viruses. CYP4A2/OR membranes metabolized lauric acid at a high rate (7 and 5.5 nmol/min/nmol P450 in the presence and absence of b5, respectively). However, arachidonic acid omega-hydroxylase activity was barely detectable. When purified OR was added to the membranes expressing CYP4A2 protein, a concentration-dependent production of 20-HETE was observed. Maximal synthesis of 20-HETE of 0.89 nmol/min/nmol P450 was achieved at OR:CYP4A2 ratio of 14:1. The omega-hydroxylation of arachidonic acid was dependent on the presence of b5. Furthermore, increasing OR concentrations yielded additional arachidonic acid metabolite identified by GC/MS as 11,12-EET. Microsomes prepared from isolated renal microvessels selectively expressed CYP4A2 protein and readily metabolized arachidonic acid to two major metabolites, 20-HETE and 11,12-DHET, the hydrolytic metabolite of 11, 12-EET. It is suggested that CYP4A2 functions as the renal microvessel arachidonate omega-hydroxylase and that it can also catalyze the 11,12-epoxidation of arachidonic acid.
20-羟基-5,8,11,14-二十碳四烯酸(20-HETE)是花生四烯酸的ω-羟基化产物,是肾脏中产生的主要代谢物。它对肾小管和血管功能以及动脉血压的长期调控具有强大的生物学效应。20-HETE的合成由CYP4A家族的酶催化,其中CYP4A2是在大鼠肾脏中表达最丰富的同工酶。我们从Lewis-Wistar大鼠的肾脏中克隆并测序了CYP4A2 cDNA,并使用杆状病毒和Sf9昆虫细胞指导其表达。通过Northern、Western和光谱分析,CYP4A2的高水平表达明显,显示微粒体蛋白的P450含量为0.3 nmol/mg。为了研究CYP4A2催化的花生四烯酸ω-羟基化,Sf9细胞用CYP4A2和NADPH细胞色素P450氧化还原酶(OR)重组病毒共感染。CYP4A2/OR膜以高速率代谢月桂酸(分别在有和没有b5的情况下,P450的代谢速率为7和5.5 nmol/min/nmol)。然而,花生四烯酸ω-羟化酶活性几乎检测不到。当将纯化的OR添加到表达CYP4A2蛋白的膜中时,观察到20-HETE的浓度依赖性产生。在OR:CYP4A2比例为14:1时,20-HETE的最大合成量为0.89 nmol/min/nmol P450。花生四烯酸的ω-羟基化依赖于b5的存在。此外,增加OR浓度产生了通过GC/MS鉴定为11,12-EET的额外花生四烯酸代谢物。从分离的肾微血管制备的微粒体选择性地表达CYP4A2蛋白,并容易将花生四烯酸代谢为两种主要代谢物,20-HETE和11,12-DHET(11,12-EET的水解代谢物)。提示CYP4A2作为肾微血管花生四烯酸ω-羟化酶起作用,并且它还可以催化花生四烯酸的11,12-环氧化。